Cresset and Optibrium Announce Technology Collaboration
Technology exchange combines unique methods for design of novel, high quality compounds in drug discovery
Advertisement
Cresset and Optibrium announced an agreement to collaborate on the development of next-generation platforms. The companies will work together, combining unique approaches to help drug discovery projects quickly identify novel, potent compounds with a high chance of success downstream.
The collaboration will involve a two-way exchange of technologies: Optibrium’s ADME models, currently provided as a plug-in module for its StarDrop™ software platform, will be made available to users of Cresset’s desktop applications. Similarly, Cresset’s FieldAlignTM software, which helps chemists understand the three-dimensional structure-activity-relationship of their chemistry in order to design active compounds, will be made available as an optional plug-in module for StarDrop, which helps project teams to confidently target compounds with a good balance of properties for their therapeutic objectives.
Other news from the department business & finance
These products might interest you
